---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "EYZhd7P+scMBDAeEwzUIqkdGD1GZo2bysF8dIwXl2xlgKdQhsnziyztQo99HgCVBBzzZpCDGOXOFMKnnLHcdSai73mp0uObWH5fBEHoCNwc1KHTj5WR4Atu/F2gu1zeTOjOMqzGLFEsmBnsPSAII5Lk65nRh1wT0BLLr7a0dIXIeWzwdGrtoDxEraygNoaKjUMCn9F/+M6q3R6OXhITBzYyCxjSmzh4i6mcFT4anRoDnZgumdQneKOJ81cHdOCH6D5lEeO2B23Zum47SJ4A5NaIOEKAx66zlfzwrG1zsAXKJ/KOWYcZ+f4W/uAxUjcJq;j1VYzTt2fPGITvUHRfxjaQ=="
---

